# Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation

Study · id `cardio:ct-nct07321899` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07321899](<https://clinicaltrials.gov/study/NCT07321899>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07321899

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1186 participants.

## Technical summary

Registry record NCT07321899. Randomized; single masking; primary purpose treatment. Start 2026-09-11 (actual); primary completion 2031-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1186 participants (planned count; ClinicalTrials.gov record NCT07321899, source copy `cardio:ctgov-nct07321899-2026-11-12`, retrieved 2026-11-18)
- Started: 2026-09-11 (actual) (ClinicalTrials.gov record NCT07321899, source copy `cardio:ctgov-nct07321899-2026-11-12`, retrieved 2026-11-18)
- Primary completion: 2031-09 (anticipated) (ClinicalTrials.gov record NCT07321899, source copy `cardio:ctgov-nct07321899-2026-11-12`, retrieved 2026-11-18)
- Completion: 2041-04 (anticipated) (ClinicalTrials.gov record NCT07321899, source copy `cardio:ctgov-nct07321899-2026-11-12`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT07321899, source copy `cardio:ctgov-nct07321899-2026-11-12`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07321899-2026-11-12`, retrieved 2026-11-18)

## The registry's words

- Brief title: Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
- Acronym: PATHFINDER
- Condition: Severe Tricuspid Regurgitation
- Intervention (Device): Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System
- Intervention (Device): Edwards EVOQUE Tricuspid Valve Replacement (TTVR) System
- Lead sponsor: Medtronic Cardiovascular
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Tricuspid regurgitation (`cardio:tricuspid-regurgitation`)
- Registry lists this organization as the lead sponsor: Medtronic (`cardio:medtronic`)

## Provenance

Content hash: 7963696fd9411025f53767408c1e151b602a5c19a239a3976737092c3333f9a5
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
